Results 111 to 120 of about 25,663 (196)

Combating Carbapenem-Resistant <i>Enterobacterales</i>: Comparative <i>In Vitro</i> Efficacy of Aztreonam-Avibactam and Ceftazidime-Avibactam and Distribution of Carbapenemase Genes. [PDF]

Antibiotics (Basel)
Yaşar Duman M, Kanat M, Tanrıverdi ES, Çilli F, Aydemir Ş.   +4 more
europepmc   +1 more source

Avibactam-based combinations for the treatment of multidrug resistant Gram-negative bacilli infections. [PDF]

Infez Med
Tiseo G, Russo A, Bartoletti M, Tumbarello M, Falcone M.   +4 more
europepmc   +1 more source

Case Report: Dynamic susceptibility-informed therapy for bile leak-associated intra-abdominal <i>Stenotrophomonas maltophilia</i> infection. [PDF]

Front Med (Lausanne)
Yang Z, Zhu B, Chen J.
europepmc   +1 more source

In vitro activity of ceftazidime-avibactam and aztreonam-avibactam against multidrug-resistant Klebsiella pneumoniae and Escherichia coli

, 2019
Background: Increasing resistance to broad-spectrum cephalosporin and carbapenem in Enterobacteriaceae makes it challenging to select appropriate antibiotics. There are limited treatment options for these pathogens.
이승철
core  

Clinical Emergence and Genomic Characterization of Aztreonam-Avibactam-Resistant <i>Escherichia coli</i> ST410 Isolates in China. [PDF]

Antibiotics (Basel)
Li X, Li P, Feng J, Fang Z, Liu S, Guo C, Hu B.   +6 more
europepmc   +1 more source

Characterization of phylogroups of <i>Klebsiella pneumoniae</i> (<i>K. quasipneumoniae</i> and <i>K. variicola</i>) harbouring <i>bla</i> _OXA-232, with special reference to ceftazidime/avibactam/aztreonam synergy and their genetic profile. [PDF]

JAC Antimicrob Resist
Banerjee T, Mishra K, Rakshit P, Yadav G, Kumar A.   +4 more
europepmc   +1 more source

<i>In vitro</i> susceptibility testing of aztreonam-avibactam against predominantly NDM-producing <i>Enterobacterales</i> in Peru. [PDF]

Microbiol Spectr
Garcia C, Reyes Y, Astocondor L, Caytuiro L, Riveros M, Amaro C, Andrade S, Hernández L, Sandoval R, Peréz-Lazo G, Cucho C, Melo M, Sabogal I, Lino L, Cuaresma E, Olivares A, Lachira A, Michilot K, Ramos J, Diaz R, Briones A, Burgos S, Cuicapuza D, Tsukayama P, Krapp F.   +24 more
europepmc   +1 more source

<i>In vitro</i> activity of the novel β-lactamase inhibitor nacubactam against a nationwide collection of carbapenem-resistant Enterobacterales in Japan. [PDF]

JAC Antimicrob Resist
Yanagihara K, Tateda K, Doi Y, Takahashi S, Ohge H, Itahashi K, Okade H, Mikamo H.   +7 more
europepmc   +1 more source

Physicochemical Stability of Aztreonam/Avibactam in Elastomeric Devices for Outpatient Parenteral Antimicrobial Therapy. [PDF]

Antibiotics (Basel)
Toro Blanch C, Larrea Urtaran X, Aguilar Salmerón R, Prat Riera A, Gómez L, Costa Pou A, Fernández-Rubio B, Herrera-Hidalgo L, Quiñones Ribas C.   +8 more
europepmc   +1 more source

In vitro activity of aztreonam/avibactam and comparators against Enterobacterales isolates from patients with hospital-acquired pneumonia, ventilator-associated pneumonia, and complicated intra-abdominal infections (ATLAS, 2021-2022). [PDF]

J Antimicrob Chemother
Yang Q, Tuon FF, Shah S, Kamat S, Mohamed N, Stone GG, Perez KK, Cantón R.   +7 more
europepmc   +1 more source